November 2016

 

Issue

Supplement

European
Supplement

Guest Chief Medical Editors’ Page

Practical Thoracic Decision Making

By Edward Y. Woo, MD; and Ian M. Loftus, MD, FRCS

COVER STORIES

Type B Dissections: What We Know and What We Don’t

By Nikolaos Tsilimparis, MD, PhD; Fiona Rohlffs, MD; Eike Sebastian Debus, MD, PhD; and Tilo Kölbel, MD, PhD

Ask the Experts: If a Complicated Type B Dissection Presents With Proximal Extension to the LCCA, How Should It Be Managed?

With Ali Azizzadeh, MD; Eric E. Roselli, MD; Matthew Thompson, MD, FRCS; and Dittmar Böckler, MD, PhD, MHBA

Current and Future Endovascular Treatment Options for TAAAs

New technologic developments have the potential to standardize procedures and offer treatment for challenging presentations.

By Timothy A. Resch, MD, PhD

Ask the Experts: Should Clinically Asymptomatic Patients With Acute Type B Dissections and Radiographic Malperfusion Be Treated?

With Wilson Szeto, MD; Ibrahim Sultan, MD; Frank R. Arko III, MD; John R. Frederick, MD; Jocelyn K. Ballast, BA; and Christoph A. Nienaber, MD, PhD, FESC, FAHA

The Current State of Branched Stent Grafts for the Aortic Arch

A review of five devices with investigational device exemptions in the United States.

By Kira N. Long, MD, and Ross Milner, MD, FACS

Does It/Will It Work: Utility of Fusion Imaging for the Aortic Arch

Current benefits of fusion imaging and potential future enhancements to aid in endovascular intervention.

By Adrien Hertault, MD; Rachel Clough, MD, PhD; Thomas Modine, MD, PhD, MBA; Dominique Fabre, MD; Richard Azzaoui, MD; Jonathan Sobocinski, MD; and Stéphan Haulon, MD, PhD

Alternative Access Options for TEVAR

Summary and review of current access methods for thoracic endovascular aneurysm repair.

By Christian C. Shults, MD; Frederick Tolle, BS; and Edward Y. Woo, MD

Aberrant Right Subclavian Arteries

A review of the etiology, incidence, clinical presentation, and rationale for repair.

By Tara M. Mastracci, MD, MSc, FRCSC, FACS, FRCS

Expanding the Landing Zone for TEVAR

A discussion of the longevity and durability of commonly used extrathoracic debranching techniques.

By Daniel K. Han, MD, RPVI; Christine Jokisch, BS; and James F. McKinsey, MD

FEATURED TECHNOLOGY

Sponsored by Boston Scientific Corporation

The Benefits of Removing Thrombus Right From the Start

Leading experts present case reports and discuss the versatility of using the AngioJet™ Thrombectomy System.

With Christopher Grilli, DO; George Kimbiris, MD; Daniel Leung, MD; Wm. Britton Eaves, MD; and John R. Ross, MD

CODING & REIMBURSEMENT

New CPT Codes for 2017

A preview of the changes ahead for interventional CPT coding effective January 2017.

By Katharine L. Krol, MD, FSIR, FACR

MEDICAL AFFAIRS

Sponsored by Medtronic

Understanding Clinical Data and Its Application to Clinical Practice

By Krishna Rocha-Singh, MD

EUROPEAN FEATURED TECHNOLOGY

Sponsored by Cordis Corporation

Taking on Complex SFA Disease

Esteemed vascular surgeon Peter Goverde discusses how interventionists should approach increasingly difficult clinical presentations.

With Peter Goverde, MD

DEPARTMENTS

An Interview With Rick de Graaf, MD, PhD

Dr. de Graaf discusses his approaches to treatment of deep venous obstruction and postthrombotic syndrome, current imaging modalities and technology for venous disease, and the benefits attending vascular congresses.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.